Variant report
Variant | esv1804683 |
---|---|
Chromosome Location | chr22:23806739-23825796 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:8)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:8 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IGLL1-2 | chr22:23822604-23822687 | ENSG00000178248 |
2 | lnc-IGLL1-2 | chr22:23824762-23824792 | ENSG00000178248 |
3 | lnc-IGLL1-2 | chr22:23816064-23816125 | ENSG00000178248 |
4 | lnc-IGLL1-2 | chr22:23825255-23825313 | ENSG00000178248 |
5 | lnc-IGLL1-2 | chr22:23815565-23815598 | ENSG00000178248 |
6 | lnc-IGLL1-2 | chr22:23812995-23813350 | ENSG00000178248 |
7 | lnc-IGLL1-2 | chr22:23812181-23812224 | ENSG00000178248 |
8 | lnc-IGLL1-2 | chr22:23812502-23812523 | ENSG00000178248 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183449619 | chr22:23806749-23806750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs62238840 | chr22:23806781-23806782 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs568737427 | chr22:23806811-23806812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs535959489 | chr22:23806836-23806837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs537529738 | chr22:23806906-23806907 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554284070 | chr22:23806970-23806971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574346720 | chr22:23806973-23806974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540226523 | chr22:23806983-23806984 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375332862 | chr22:23807008-23807009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567491035 | chr22:23807020-23807021 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143053308 | chr22:23807029-23807030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565457737 | chr22:23807079-23807080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6003727 | chr22:23807100-23807101 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531165361 | chr22:23807128-23807129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544710174 | chr22:23807142-23807143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114028250 | chr22:23807174-23807175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553328892 | chr22:23807175-23807176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529999280 | chr22:23807199-23807200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112310483 | chr22:23807304-23807305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546985431 | chr22:23807308-23807309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566623382 | chr22:23807368-23807369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73391303 | chr22:23807446-23807447 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs568700468 | chr22:23807511-23807512 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537694012 | chr22:23807522-23807523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538899601 | chr22:23807525-23807526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187835400 | chr22:23807527-23807528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568157183 | chr22:23807561-23807562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12168060 | chr22:23807581-23807582 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs9624182 | chr22:23807603-23807604 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs576792860 | chr22:23807632-23807633 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545701577 | chr22:23807639-23807640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190887487 | chr22:23807671-23807672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs62238841 | chr22:23807720-23807721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544825958 | chr22:23807728-23807729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2000464 | chr22:23807739-23807740 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs115829100 | chr22:23807798-23807799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs147430267 | chr22:23807837-23807838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115123976 | chr22:23807842-23807843 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560520130 | chr22:23807919-23807920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574721018 | chr22:23807935-23807936 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532439208 | chr22:23807963-23807964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs151302043 | chr22:23807996-23807997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540946913 | chr22:23808013-23808014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183153968 | chr22:23808037-23808038 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531362378 | chr22:23808083-23808084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547997351 | chr22:23808090-23808091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs568034434 | chr22:23808155-23808156 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533864225 | chr22:23808157-23808158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560281194 | chr22:23808183-23808184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533767676 | chr22:23808189-23808190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Asthma | 21956041 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
22q11.23 microdeletion syndrome | 19193630 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Schizophrenia | 17989066 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Li-fraumeni syndrome | 18685109 | CNVD |
Breast cancer | 20409316 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Cancer | 19424424 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
abnormal development | 18461090 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:23792800-23812800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr22:23800400-23815200 | Weak transcription | Primary B cells from cord blood | blood |
3 | chr22:23801600-23806800 | Weak transcription | Ovary | ovary |
4 | chr22:23803200-23806800 | Weak transcription | Thymus | Thymus |
5 | chr22:23806000-23808600 | Enhancers | Dnd41 | blood |
6 | chr22:23806400-23807200 | Enhancers | Fetal Thymus | thymus |
7 | chr22:23806800-23807000 | Enhancers | Ovary | ovary |
8 | chr22:23806800-23807000 | Enhancers | Thymus | Thymus |
9 | chr22:23807000-23808200 | Weak transcription | Ovary | ovary |
10 | chr22:23807200-23808000 | Weak transcription | Fetal Thymus | thymus |
11 | chr22:23808000-23808800 | Enhancers | Fetal Thymus | thymus |
12 | chr22:23808800-23813000 | Weak transcription | A549 | lung |
13 | chr22:23809400-23810600 | Enhancers | HepG2 | liver |
14 | chr22:23812200-23812400 | Enhancers | HepG2 | liver |
15 | chr22:23812800-23813000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr22:23813000-23814400 | Enhancers | HepG2 | liver |
17 | chr22:23813200-23813400 | Enhancers | A549 | lung |
18 | chr22:23813400-23814000 | Enhancers | Fetal Brain Male | brain |
19 | chr22:23813800-23814200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
20 | chr22:23814000-23815600 | Enhancers | Primary B cells from peripheral blood | blood |
21 | chr22:23814000-23815600 | Weak transcription | Fetal Brain Male | brain |
22 | chr22:23814200-23815400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
23 | chr22:23815200-23815400 | Enhancers | Primary B cells from cord blood | blood |
24 | chr22:23815400-23817000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
25 | chr22:23815600-23816400 | Enhancers | Fetal Brain Male | brain |
26 | chr22:23816000-23816200 | Enhancers | Brain Cingulate Gyrus | brain |
27 | chr22:23816000-23817200 | Enhancers | Brain Germinal Matrix | brain |
28 | chr22:23816200-23817000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
29 | chr22:23816200-23817000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
30 | chr22:23816200-23817000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
31 | chr22:23816200-23817000 | Enhancers | Brain Inferior Temporal Lobe | brain |
32 | chr22:23819600-23821400 | Enhancers | Dnd41 | blood |
33 | chr22:23820400-23820600 | Enhancers | Small Intestine | intestine |
34 | chr22:23820400-23820800 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
35 | chr22:23820400-23820800 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
36 | chr22:23820600-23821200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
37 | chr22:23821400-23825200 | Weak transcription | Dnd41 | blood |
38 | chr22:23823600-23824200 | Enhancers | Fetal Thymus | thymus |
39 | chr22:23825200-23825800 | Enhancers | Dnd41 | blood |